Total Payments
$16,816
2024 Payments
$2,139
Companies
45
Transactions
747
Medicare Patients
2,222
Medicare Billing
$176,217
Payment Breakdown by Category
Food & Beverage$14,945 (88.9%)
Consulting$1,275 (7.6%)
Education$396.17 (2.4%)
Other$200.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,945 | 734 | 88.9% |
| Consulting Fee | $1,275 | 1 | 7.6% |
| Education | $396.17 | 11 | 2.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,687 | 94 | $0 (2024) |
| GENZYME CORPORATION | $1,208 | 48 | $0 (2024) |
| LEO Pharma Inc. | $1,152 | 52 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,104 | 64 | $0 (2024) |
| MAYNE PHARMA INC. | $936.36 | 113 | $0 (2020) |
| Amgen Inc. | $896.65 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $757.63 | 35 | $0 (2024) |
| Allergan, Inc. | $627.47 | 18 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $607.66 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $526.38 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,139 | 70 | ABBVIE INC. ($695.91) |
| 2023 | $2,884 | 105 | ABBVIE INC. ($615.87) |
| 2022 | $1,843 | 73 | LEO Pharma Inc. ($357.53) |
| 2021 | $1,607 | 65 | Allergan, Inc. ($312.70) |
| 2020 | $1,337 | 61 | Galderma Laboratories, L.P. ($252.98) |
| 2019 | $1,402 | 72 | Mayne Pharma Inc. ($309.44) |
| 2018 | $3,010 | 131 | AbbVie, Inc. ($1,468) |
| 2017 | $2,593 | 170 | Aqua Pharmaceuticals ($367.75) |
All Payment Transactions
747 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Solta Medical, a division of Bausch Health US, LLC | Fraxel, Clear & Brilliant | Food and Beverage | In-kind items and services | $23.82 | General |
| 11/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: Immunology | ||||||
| 11/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $38.11 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $145.57 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/05/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Food and Beverage | In-kind items and services | $20.06 | General |
| 10/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.91 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Dermatology | ||||||
| 10/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.26 | General |
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Immunology | ||||||
| 08/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.63 | General |
| 08/15/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $113.46 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 610 | 1,082 | $80,290 | $49,012 |
| 2022 | 11 | 558 | 1,058 | $76,863 | $48,069 |
| 2021 | 12 | 544 | 942 | $65,807 | $40,109 |
| 2020 | 12 | 510 | 1,054 | $59,838 | $39,028 |
Total Patients
2,222
Total Services
4,136
Medicare Billing
$176,217
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 166 | $15,571 | $9,700 | 62.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 82 | 103 | $12,244 | $8,428 | 68.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 91 | 115 | $12,553 | $6,159 | 49.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 25 | $7,907 | $5,890 | 74.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 61 | $8,029 | $5,394 | 67.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 85 | 114 | $8,461 | $3,782 | 44.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 13 | 18 | $3,162 | $2,312 | 73.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 59 | $3,310 | $2,248 | 67.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 66 | 365 | $2,656 | $1,880 | 70.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $2,665 | $1,544 | 57.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 15 | $2,683 | $981.82 | 36.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 18 | $1,049 | $693.08 | 66.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 140 | $13,273 | $8,521 | 64.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 84 | $11,269 | $7,793 | 69.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 75 | 94 | $11,540 | $7,693 | 66.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 20 | 23 | $7,374 | $5,466 | 74.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 71 | 90 | $10,347 | $5,406 | 52.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 85 | 108 | $7,797 | $3,625 | 46.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 17 | 24 | $4,264 | $3,220 | 75.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 69 | 429 | $3,116 | $2,100 | 67.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 26 | 38 | $2,052 | $1,568 | 76.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,200 | $1,462 | 34.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $1,632 | $1,216 | 74.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 74 | 93 | $10,950 | $7,583 | 69.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 95 | $11,033 | $6,851 | 62.1% |
About Dr. Heather Richmond, M.D
Dr. Heather Richmond, M.D is a Dermatology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1497051023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Richmond, M.D has received a total of $16,816 in payments from pharmaceutical and medical device companies, with $2,139 received in 2024. These payments were reported across 747 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,945).
As a Medicare-enrolled provider, Richmond has provided services to 2,222 Medicare beneficiaries, totaling 4,136 services with total Medicare billing of $176,217. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Houston, TX
- Active Since 01/29/2011
- Last Updated 11/19/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1497051023
Products in Payments
- Humira (Biological) $1,695
- DUPIXENT (Biological) $1,472
- DORYX (Drug) $884.64
- Otezla (Drug) $817.50
- ADBRY (Biological) $765.22
- SKYRIZI (Biological) $731.93
- RINVOQ (Biological) $669.59
- ILUMYA (Biological) $475.40
- EUCRISA (Drug) $407.54
- TALTZ (Drug) $399.01
- TREMFYA (Drug) $398.24
- BOTOX (Biological) $348.19
- ENSTILAR (Drug) $343.05
- EPIDUO FORTE (Drug) $264.87
- COSENTYX (Biological) $263.58
- OPZELURA (Drug) $239.32
- REMICADE (Biological) $205.02
- DUPIXENT (Drug) $180.34
- ORACEA (Drug) $169.70
- Cimzia (Drug) $168.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Houston
Dr. Alpesh Desai
Dermatology — Payments: $1.4M
Dermatology $1.4M
Dr. Michael Migden, Md, MD
Dermatology — Payments: $379,143
Dermatology $379,143
Dr. Geeta Patel, D.o, D.O
Dermatology — Payments: $341,210
Dermatology $341,210
Catherine Papasakelariou, M.d, M.D
Dermatology — Payments: $270,262
Dermatology $270,262
Megan Couvillion, Md, MD
Dermatology — Payments: $154,211
Dermatology $154,211
Suzanne Bruce, M.d, M.D
Dermatology — Payments: $135,195
Dermatology $135,195